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Abstract - This paper discusses a proposed method using 
a combination of advanced statistical approaches (e.g., 
meta-analysis, regression, structural equation modeling) 
that will not only convert different empirical results into 
a common metric for scaling individual PSFs effects, but 
will also examine the complex interrelationships among 
PSFs.  Furthermore, the paper discusses how the derived 
statistical estimates (i.e., effect sizes) can be mapped onto 
a HRA method (e.g. SPAR-H) to generate HEPs that can 
then be use in probabilistic risk assessment (PRA).  The 
paper concludes with a discussion of the benefits of using 
academic literature in assisting HRA analysts in 
generating sound HEPs and HRA developers in 
validating current HRA models and formulating new 
HRA models. 
I. INTRODUCTION 
In many current HRA methods, the quantification 
process begins with the user identifying the task of 
interest as well as determining the task’s nominal 
human error probability (NHEP).  The NHEP is 
simply the base-rate for an error to occur under normal 
operating conditions.  For example, the Standardized 
Plant Analysis Risk HRA (SPAR-H) method places a 
NHEP of 0.01 (or 1E-2) for cognitively engaging tasks 
and NHEP of 0.001 (or 1E-3) for action-related tasks 
[1].  Thus according to SPAR-H, under normal 
operating conditions an individual has a 1 in 100 
chance of committing a cognitive error while a 1 in 
1000 chance of committing an action-oriented error.  
After determining the task NHEP, the user, typically a 
human reliability analyst, then identifies PSFs that are 
believed to affect the task performance. The PSFs are 
then quantified and used to modify (i.e., enhance or 
degrade) the calculated NHEPs to produce an HEP.  
Thus, identifying and quantifying PSFs are critical 
steps in the quantification process. 
Thus, identifying and quantifying performance-
shaping factors (PSFs) are critical steps in many 
human reliability analysis (HRA) methods.  However, 
the lack of empirical data in a form that these HRA 
methods can use to base PSF values on has been 
challenging in terms of helping the HRA analyst 
derive sound human error probability (HEP) estimates 
and supporting HRA method developers in 
formulating and validating HRA models. The lack of 
data in a readily usable form for PSF estimation stems 
from two challenges: 1) scaling individual PSF effects 
from different empirical sources, and 2) partitioning 
the inter-relational effects between the different types 
of PSFs (as illustrated in Fig. 1 for SPAR-H). 
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Figure 1. Relationships between PSFs in SPAR-H, where solid lines 
indicate a strong relationship and dotted lines indicate a moderate 
relationship (from Reference [1])
Scaling the magnitude of an individual PSF to a 
generic PSF is very difficult because it requires a well-
controlled experiment in which the researcher 
manipulates the effect of an individual PSF on 
performance while holding all other PSFs constant 
(thus, preventing spurious effects and/or confounds).  
Only in an experimental design can one reveal the 
relative effect of a PSF on performance.  While such 
requirements may be outside the practical realm of 
industry control, the academic literature is full of well-
controlled experiments examining PSFs on a wide-
variety of tasks.  Unfortunately, the rich data in the 
academic literature has not been fully captured by 
HRA analysts and methods developers because most 
of the experimental results are not reported in terms of 
human error probabilities.  More importantly, these 
experimental results tend to be reported in different 
scaling metrics (e.g., some results are reported in 
terms of means, chi-squares, proportions, correlations, 
t-statistics, F-statistics, etc.), thus making it difficult 
for an analyst to combine or average the results across 
different studies.  Because of this, there is no standard 
outside expert estimation for an analyst to use in 
estimating the magnitude of PSF effects.  
Consequently, this can lead to inconsistent estimates 
among different users or methods. To further 
complicate the scaling issue, many PSFs are assumed 
to co-occur and in some cases, can exert influence on 
other PSFs in moderating human performance. To 
date, the exact interrelationship between PSFs is 
unknown. 
One solution to the scaling issue consists of 
compiling the database with relevant empirical 
literature on PSFs as well as scoping the statistical 
literature for an approach to convert different scaling 
metrics onto a common scale.  At present, a database  
created by the Idaho National Laboratory (INL) has 
successfully documented a large number of empirical 
studies on PSFs.  This allows the user to search the 
database for relevant PSFs that he/she is interested in 
exploring. 
One statistical approach called meta-analysis
(specifically, meta-analysis’ statistics of effect size), 
not only allows users to convert different empirical 
results onto a common metric in scaling individual 
PSFs effects but also allows users to examine the 
complex interrelationships among PSFs. The 
remaining portion of this paper describes what meta-
analysis is and how meta-analysis can assist human 
reliability analysts.  It will also describe how meta-
analysis results can be mapped onto the example HRA 
method of SPAR-H to generate HEPs that can then be 
used in PRA.  Finally, a step-by-step example is 
provided to assist users in conducting a meta-analysis. 
II. META-ANALYSIS AND ITS        
IMPLICATIONS TO SCALING       
PERFORMANCE SHAPING FACTORS 
Meta-analysis is a method used to review research 
literature.  Instead of conducting original research 
studies, meta-analysis uses the information that has 
already been collected in the literature by pooling and 
converting those different reported statistics onto a 
common metric (i.e., effect size), so that more 
generalizable results can be interpreted  [2].  Like 
basic experimental designs, a meta-analysis has 
independent and dependent variables.  The 
independent variables in meta-analysis are the 
reviewed studies that contain the variables of interest 
(in our case, PSFs) while the dependent measure(s) are 
the reviewed studies’ outcome measures (e.g., 
response times or error rates).  Importantly, meta-
analysis can convert different reported statistics onto a 
common metric known as effect size (typically 
Cohen’s d).  The conceptual basis of effect size is 
analogous to Fischer’s standardizeD (Z) scores, in that 
results are transformed into a standardized (d) metric 
scale [3].  That is, effect size is the term given to the 
degree of change in the variable under study.  The 
degree of change relates to the phenomenon under 
investigation (e.g., stress), the degree that it is present 
in the population, and its expressed degree of 
difference from the null hypothesis, where the null 
hypothesis is that there is no effect. 
Typically, effect size is calculated by subtracting the 
mean of the control group from the mean of the 
treatment group and divided by the pooled standard 
deviation of the two groups [2].  Thus, using Table. 1, 
an effect size of 0.7 between studies examining stress 
and no stress means that, on average, individuals in the 
stress studies performed better than 76% of the 
individuals in the no stress condition.  Conversely, an 
effect size of -0.8 on studies examining stress and no 
stress means that, on average, individuals in the no 
stress condition performed better than 79% of the 
individuals in the stress condition.  A more 
conventional and easy method to interpret effect size is 
to use Cohen’s metric of 0.2 as “small effect size”, 0.5 
as “medium effect size”, and 0.8 as “large effect size” 
[3].  Either way, effect size allows users to aggregate 
numerous studies independent of the original reported 
statistics (e.g., chi-square, F-test, t-test, means).  For 
simplicity, this document focuses on Cohen’s metrics. 
TABLE 1. INTERPRETING EFFECT SIZE  
(TAKEN FROM REFERENCE[3]).
Effect 
Size (d)
%ile Effect 
Size (d)
%ile Effect 
Size (d)
%ile
0.0 50% 0.6 73% 1.4 92%
0.1 54% 0.7 76% 1.6 95%
0.2 58% 0.8 79% 1.8 96%
0.3 62% 0.9 82% 2.0 98%
0.4 66% 1.0 84% 2.5 99%
0.5 69% 1.2 88% 2.8 99.9%
The main strength of meta-analysis comes from its 
ability to summarize research findings across different 
studies.  This procedure makes it possible to convert 
different statistical results onto a common scale as 
well as examining for underlying relationships 
between variables, such as moderator variables.  Other 
strong points of meta-analysis are that it does not rely 
on sample size, can handle large numbers of studies, 
and protects against over-interpreting differences 
across studies.  The next sections of this paper will 
focus on how to calculate effect sizes to determine 
relative effects of individual PSFs as well as guidance 
in examining the interrelationship between PSFs, and, 
finally, how Cohen’s d can be mapped onto SPAR-H 
to produce HEPs. 
III. CALCULATING EFFECT SIZE (d) TO 
DETERMINE RELATIVE EFFECTS OF 
INDIVIDUAL PSFs IN EMPIRICAL LITERATURE 
Eq. 1 below is commonly used to convert means and 
standard deviations into effect sizes and uses the 
“pooled standard deviation” in Eq. 2.  The reason for 
using the pooled standard deviation instead of the 
more familiar control group standard deviation is 
because many studies may lack a true control group or 
the control group sample size is relatively small.  In 
such cases, the pooled standard deviation reflects the 
best estimate of the ‘population’ standard deviation 
[3]. 
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Where, 
ESsm = standardized mean difference effect size 
X1 = mean of control 
X2 = mean of test 
spooled = pooled standard deviation 
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Where, 
ESsm = standardized mean difference effect size 
s1 2 = variance of sample 1 
s22 = variance of sample 2 
n1 = control sample size 
n2 = test sample size 
spooled = pooled sample deviation 
There are cases in the database when both the means 
and standard deviations are not reported. Instead, the 
reported statistics are simply F-statistics or t-statistics.
In such cases, it is recommended that the user use Eq. 
3 and Eq. 4.  When the reported statistics is chi-square, 
the analyst should use Eq. 5.  
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Where, 
ESsm = standardized mean difference effect size 
n1 = control sample size 
n2 = test sample size 
F = F-test value 
                       ESsm ? t
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n1n2
                      (4) 
Where, 
ESsm = standardized mean difference effect size 
n1 = control sample size 
n2 = test sample size 
t = t-test value 
                         ESsm ? 2
? 2
N ? ? 2
                       (5) 
Where, 
ESsm = standardized mean difference effect size 
?2 = Chi-Square Value 
N = total sample size 
There may be cases when the user may want to 
aggregate two different statistics such as an F-statistics 
(i.e., analysis between dichotomous variables) and a 
correlation (i.e., analysis between two continuous 
variables).  In such cases, the user is directed to follow 
the r to d transformation of Eq. 6. 
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Where,  
r = correlation coefficient 
Finally, the user should be aware that in some cases, 
there may be only a small number of relevant PSF 
studies available in the database that the analyst is 
interested in, for example, organizational factors.  
When using only a small number of studies in a meta-
analysis, the user must be aware of sampling error in 
that the pooled standard deviation is only an estimate 
and does not reflect the true population standard 
deviation [3].  To correct for sampling error, the user 
should use an unbiased estimate of Cohen’s d.
Specifically, the unbiased estimate of d is 
approximately equal to the calculated value of: 
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Where, 
NE = test sample size 
NC = control sample size 
IV. RELATIONSHIP BETWEEN PSFs 
As discussed earlier, some PSFs are considered to 
be non-orthogonal.  Because of this, users should be 
aware of studies in the database that examine two or 
more PSFs within a single experiment, since the 
relative effect of a single PSF on performance may be 
modulated by the other PSF(s).  These indirect 
influences by other PSFs can be described as 
moderators and mediators.  A moderator is a third 
variable that can affect the direction and/or strength 
between the primary variable of interest and the 
outcome measures.  Thus, in terms of statistics, 
moderators lead to interactions [4].  For example, 
stress may have a relatively strong effect on 
performance during high workload but relatively weak 
effect during low workload.  Whereas, mediation is 
where the primary variable affects a third variable 
directly, which then affects the outcome measure.  For 
example, stress affects workload that then affects 
performance (see Fig. 2).  Thus, when an analyst
includes a study that consists of more than one PSF, a 
moderator/mediator analysis is recommended. 
Figure 2. Examples of moderator and mediator effects 
In examining moderation effects, the user is looking 
for a statistical interaction. Thus, a user can conduct 
numerous tests in examining statistical interactions 
depending on the PSF variable types: 
? If the PSFs are all categorical, then use a chi-
square statistic; 
? If one PSF is categorical and another is 
continuous, then use an Analysis of Variance 
(ANOVA); 
? If the PSFs are all continuous, then use regression 
analysis.
On the other hand, in mediation analysis, it has been 
recommended to use structural equation modeling.  In 
fact, although moderation analysis can be examined 
with the above statistics, researchers have supported 
the structural equation modeling approach for both 
moderators and mediators [4]. Nevertheless, for 
simplicity, chi-square, ANOVA, and regression 
analysis are suitable statistics in examining 
moderators. 
V. MAPPING COHEN’S d TO SPAR-H                  
TO PRODUCE HEPS 
In HRA methods (e.g., SPAR-H), the analysts are 
required to evaluate the magnitude of PSF effects.  
Because these PSF evaluations are used to modify 
NHEPs to obtain HEPs, it is critical that the reliability 
between analysts be high to ensure the reproducibility 
of results.  The concern of low inter-rater reliability is 
always present when the evaluation is subjective in 
nature.  The effect size approach can be useful here in 
aiding the analyst in evaluating the magnitude of the 
PSFs.  As mentioned earlier, a conventional method to 
interpret effect size is to use Cohen’s effect size metric 
of 0.2 as “small effect size,” 0.5 as “medium effect 
size,” and 0.8 as “large effect size.”  Analysts can use 
Cohen’s effect size metric in scaling their PSF ratings.  
In some instances, Cohen’s effect size metric can be 
directly mapped to a HRA PSF rating scales as shown 
in Table 2. 
In other cases, analysts can use Cohen’s effect size 
metric as a mean to gauge the appropriate level of 
PSFs. Thus, Cohen’s effect size can be useful in 
increasing analysts’ inter-rater reliability by bringing 
some standardization in the HRA methods of 
evaluating PSFs. 
TABLE 2. EXAMPLE OF SCALING COHEN’S EFFECT SIZE 
METRIC TO SPAR-H PSF RATINGS 
PSF Level/Multiplier Effect Size 
(d)
Extreme 0.8 
High 0.5 
Nominal 0.2 
Stress/
Stressors 
Insufficient Information 
Highly complex 0.8 
Moderately complex 0.5 
Nominal 0.2 
Obvious diagnosis 
Complexity 
Insufficient Information 
Low 0.5 
Nominal 0.2 
High 0.8 
Experience/
Training 
Insufficient Information 
In summary, this section has illustrated how an 
analyst can use the database to extract quantitative 
information on PSFs of interest, calculate effect sizes, 
and use Cohen’s effect size metric to gauge 
appropriate PSF ratings within HRA methods to obtain 
HEPs.  The next section illustrates a practical example 
how an analyst can use this method for HRA. 
VI. ILLUSTRATION OF A META-ANALYSIS 
Steps in conducting a meta-analysis for the purpose 
of obtaining HEPs are as follows.  First, the user must 
select a PSF or PSFs he or she wants to examine in the 
literature.  Then, the user then extracts the necessary 
quantitative information (e.g., means, F-statistics) 
from the literature to calculate effect sizes.  Next, 
depending on whether the study examines two or more 
PSFs, the user should perform a moderator or mediator 
analysis to be certain that the calculated effect size 
value is valid.  Finally, using Cohen’s effect size 
metric, the user can gauge the appropriate scaling level 
of PSFs in a HRA method. 
To give a practical example, (adapted from 
Reference [5]), one concern in spaceflight could be 
that astronauts do not sleep well, given their 
environment (e.g., environmental noises from 
instruments, weightlessness).  Thus, an analyst may be 
interested in examining whether an individual’s 
fatigue due to sleep loss can affect astronaut’s 
performance and to what degree.  Next, the user 
searches through the database using “fatigue” and 
“sleep” as guiding keywords and extracts relevant 
quantitative information to use in effect size 
calculation.  Also during this stage, the analyst should 
make note of any other PSFs (e.g., workload) or other 
variables (e.g., gender) that were present in the 
selected studies, which he or she believes may mediate 
and/or moderate the PSF effect.  To do this, it is 
recommended that the user construct a “data coding 
log” to organize different factors that he or she may 
want to use as a moderator or mediator variable.  
Figure 2 provides a simple example of a data-coding 
log. 
After obtaining and logging the PSF quantitative 
information from the database, the user can use Eq. 1 
through Eq. 7 to convert the quantitative information 
into effect sizes.  Appendix A illustrates the results of 
the effect size calculation. 
TABLE 3. EXAMPLE OF A DATA CODING LOG FOR AN 
INDIVIDUAL EMPIRICAL STUDY ENTRY 
Study Quantitative Information Analyst 
Input
Length of Sleep Deprivation
Output Measure: 
(simple reaction time, error rates, other performance 
measures) 
Performance direction after test condition (e.g., better 
(+), worse (-))
Sample size of control group and test group
Type of stat used 
(means & Stdev, proportions or frequencies, 
significance test (e.g., t-test, F-value, chi-squared, p-
value) quantitative results cannot be calculated)
TABLE 3. EXAMPLE OF A DATA CODING LOG FOR AN 
INDIVIDUAL EMPIRICAL STUDY ENTRY (CON’T) 
The meta-analysis performed on these data resulted 
in a overall effect size of -0.6341.  Using Table 1 to 
determine effect size shows that the average individual  
in the non-sleep deprived condition performed better 
than 73% of the individuals in the sleep deprived 
condition.  In terms of Cohen’s effect size metric, 
sleep deprivation has a “medium effect” on 
performances. 
Moderator and mediator analyses were not 
performed in this example because this meta-analysis 
was performed on a small sample of research articles 
on fatigue, and doing these analyses at this point 
would have been premature.  Ideally, all relevant 
articles should be included in the meta-analysis before 
these ancillary tests are performed.  Finally, the 
analyst can use Cohen’s effect size metric to produce 
HEPs.  For example, using SPAR-H, fatigue is a 
component of the “Fitness for Duty” PSF.  As Table 4 
shows, because SPAR-H uses only two levels of 
degraded performance for “Fitness for Duty,” an 
analyst would map Cohen’s “large” effect size to 
“Unfit,” thus obtaining an HEP of 1.0 (failure).  A 
“medium” effect size should be mapped to “Degraded 
Fitness”; thus, obtaining a multiplier of 5.0 for this 
PSF.  If the calculated effect size was “low” on 
Cohen’s metric, the analyst should rate “Fitness for 
Duty” as nominal and obtain a PSF multiplier of 1.0. 
TABLE 4. FITNESS FOR DUTY PSF LEVELS IN SPAR-H 
Unfit p(failure) = 1.0 
Degraded Fitness 5 
Nominal 1
Fitness 
for Duty 
Insufficient Information 1
VII. CONCLUSION AND NEXT STEPS 
Meta-analytic techniques may be use to aggregate or 
formulate new HEP values based on existing data.  
Cohen’s effect size metric provides a systematic guide 
for analyst to use to evaluate the severity of PSFs on 
performance, thus leading to higher inter-rater 
reliability as well as reproducibility of results.  
Methods developers can examine the interrelationship 
between PSFs by setting each PSF as moderating or 
mediating variables.  After calculating each PSF’s 
effect size, a methods developer can perform a 
structural equation modeling analysis to examine the 
many interrelationships (i.e., moderating and 
mediating relationships) among PSFs. 
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Study Quantitative Information Analyst 
Input
Specialty field of sample source (e.g., astronauts, 
pilots, military, NPP workers, others) 
Average Hours of Sleep
Experimental Design:   
(e.g., within vs. between group)
Types of Experimental Conditions 
(e.g., kept active, deprived of caffeine, kept at lab, 
other)
Other PSF presence (e.g., available time, 
stress/stressors, complexity, experience/training, 
procedures, ergonomics/HMI, work process)
Figure 2. Summary of effect size calculations. 
